Cargando…

Genomic reconstruction and features of glycosylation pathways in the apicomplexan Cryptosporidium parasites

Cryptosporidium is a genus of apicomplexan parasites infecting humans or other vertebrates. The majority of the Cryptosporidium species live in host intestines (e.g., C. parvum, C. hominis and C. ubiquitum), but there are a few gastric species (e.g., C. muris and C. andersoni). Among them, C. parvum...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dongqiang, Wang, Chenchen, Zhu, Guan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713705/
https://www.ncbi.nlm.nih.gov/pubmed/36465557
http://dx.doi.org/10.3389/fmolb.2022.1051072
_version_ 1784842068168802304
author Wang, Dongqiang
Wang, Chenchen
Zhu, Guan
author_facet Wang, Dongqiang
Wang, Chenchen
Zhu, Guan
author_sort Wang, Dongqiang
collection PubMed
description Cryptosporidium is a genus of apicomplexan parasites infecting humans or other vertebrates. The majority of the Cryptosporidium species live in host intestines (e.g., C. parvum, C. hominis and C. ubiquitum), but there are a few gastric species (e.g., C. muris and C. andersoni). Among them, C. parvum is the most important zoonotic species, for which a number of glycoproteins have been reported for being involved in the interacting with host cells. However, little is known on the cryptosporidium glycobiology. Information on the glycosylation pathways in Cryptosporidium parasites remains sketchy and only a few studies have truly determined the glycoforms in the parasites. Here we reanalyzed the Cryptosporidium genomes and reconstructed the glycosylation pathways, including the synthesis of N- and O-linked glycans and GPI-anchors. In N-glycosylation, intestinal Cryptosporidium possesses enzymes to make a simple precursor with two terminal glucoses on the long arm (i.e., Glc(2)Man(5)GlcNAc(2) vs. Glc(3)Man(9)GlcNAc(2) in humans), but gastric species only makes a simpler precursor containing only the “core” structure (i.e., Man(3)GlcNAc(2)). There is an ortholog of glucosidase II (GANAB) in all Cryptosporidium species, for which the authenticity is questioned because it contains no signal peptide and exist in gastric species lacking terminal glucoses for the enzyme to act on. In O-linked glycosylation, all Cryptosporidium species may attach one-unit HexNAc (GalNAc and GlcNAc) and two-unit Fuc-type (Man-Fuc) glycans to the target proteins. Cryptosporidium lacks enzymes to further process N- and O-glycans in the Golgi. The glycosylphosphatidylinositol (GPI)-anchor in Cryptosporidium is predicted to be unbranched and unprocessed further in the Golgi. Cryptosporidium can synthesize limited nucleotide sugars, but possesses at least 12 transporters to scavenge nucleotide sugars or transport them across the ER/Golgi membranes. Overall, Cryptosporidium makes much simpler glycans than the hosts, and the N-glycoforms further differ between intestinal and gastric species. The Cryptosporidium N- and O-glycans are neutrally charged and have limited capacity to absorb water molecules in comparison to the host intestinal mucins that are negatively charged and highly expandable in waters.
format Online
Article
Text
id pubmed-9713705
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97137052022-12-02 Genomic reconstruction and features of glycosylation pathways in the apicomplexan Cryptosporidium parasites Wang, Dongqiang Wang, Chenchen Zhu, Guan Front Mol Biosci Molecular Biosciences Cryptosporidium is a genus of apicomplexan parasites infecting humans or other vertebrates. The majority of the Cryptosporidium species live in host intestines (e.g., C. parvum, C. hominis and C. ubiquitum), but there are a few gastric species (e.g., C. muris and C. andersoni). Among them, C. parvum is the most important zoonotic species, for which a number of glycoproteins have been reported for being involved in the interacting with host cells. However, little is known on the cryptosporidium glycobiology. Information on the glycosylation pathways in Cryptosporidium parasites remains sketchy and only a few studies have truly determined the glycoforms in the parasites. Here we reanalyzed the Cryptosporidium genomes and reconstructed the glycosylation pathways, including the synthesis of N- and O-linked glycans and GPI-anchors. In N-glycosylation, intestinal Cryptosporidium possesses enzymes to make a simple precursor with two terminal glucoses on the long arm (i.e., Glc(2)Man(5)GlcNAc(2) vs. Glc(3)Man(9)GlcNAc(2) in humans), but gastric species only makes a simpler precursor containing only the “core” structure (i.e., Man(3)GlcNAc(2)). There is an ortholog of glucosidase II (GANAB) in all Cryptosporidium species, for which the authenticity is questioned because it contains no signal peptide and exist in gastric species lacking terminal glucoses for the enzyme to act on. In O-linked glycosylation, all Cryptosporidium species may attach one-unit HexNAc (GalNAc and GlcNAc) and two-unit Fuc-type (Man-Fuc) glycans to the target proteins. Cryptosporidium lacks enzymes to further process N- and O-glycans in the Golgi. The glycosylphosphatidylinositol (GPI)-anchor in Cryptosporidium is predicted to be unbranched and unprocessed further in the Golgi. Cryptosporidium can synthesize limited nucleotide sugars, but possesses at least 12 transporters to scavenge nucleotide sugars or transport them across the ER/Golgi membranes. Overall, Cryptosporidium makes much simpler glycans than the hosts, and the N-glycoforms further differ between intestinal and gastric species. The Cryptosporidium N- and O-glycans are neutrally charged and have limited capacity to absorb water molecules in comparison to the host intestinal mucins that are negatively charged and highly expandable in waters. Frontiers Media S.A. 2022-11-17 /pmc/articles/PMC9713705/ /pubmed/36465557 http://dx.doi.org/10.3389/fmolb.2022.1051072 Text en Copyright © 2022 Wang, Wang and Zhu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Wang, Dongqiang
Wang, Chenchen
Zhu, Guan
Genomic reconstruction and features of glycosylation pathways in the apicomplexan Cryptosporidium parasites
title Genomic reconstruction and features of glycosylation pathways in the apicomplexan Cryptosporidium parasites
title_full Genomic reconstruction and features of glycosylation pathways in the apicomplexan Cryptosporidium parasites
title_fullStr Genomic reconstruction and features of glycosylation pathways in the apicomplexan Cryptosporidium parasites
title_full_unstemmed Genomic reconstruction and features of glycosylation pathways in the apicomplexan Cryptosporidium parasites
title_short Genomic reconstruction and features of glycosylation pathways in the apicomplexan Cryptosporidium parasites
title_sort genomic reconstruction and features of glycosylation pathways in the apicomplexan cryptosporidium parasites
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713705/
https://www.ncbi.nlm.nih.gov/pubmed/36465557
http://dx.doi.org/10.3389/fmolb.2022.1051072
work_keys_str_mv AT wangdongqiang genomicreconstructionandfeaturesofglycosylationpathwaysintheapicomplexancryptosporidiumparasites
AT wangchenchen genomicreconstructionandfeaturesofglycosylationpathwaysintheapicomplexancryptosporidiumparasites
AT zhuguan genomicreconstructionandfeaturesofglycosylationpathwaysintheapicomplexancryptosporidiumparasites